Abstract
Healthcare associate infections (HAIs) caused by multi-resistant microorganisms pose a challenging to clinical practice, as they have a negative impact on associated morbidity, lethality, hospitalization time and costs generated to the health system. Gram-negative bacilli with resistance to multiple antimicrobials, including carbapenems and polymyxins, are currently the most worrying, sin…